Mary Ann Cloyd - 16 May 2025 Form 4 Insider Report for EKSO BIONICS HOLDINGS, INC. (EKSO)

Role
Director
Signature
/s/ Jerome Wong, as Attorney-in-Fact
Issuer symbol
EKSO
Transactions as of
16 May 2025
Net transactions value
$0
Form type
4
Filing time
19 May 2025, 19:07:33 UTC
Previous filing
07 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cloyd Mary Ann Director 101 GLACIER POINT, SUITE A, SAN RAFAEL /s/ Jerome Wong, as Attorney-in-Fact 19 May 2025 0001666769

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EKSO Common Stock Award $0 +236,202 +107% $0.000000 456,707 16 May 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting.
F2 This award of RSUs was granted effective May 16, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders (the "Grant Date"), pursuant to an automatic annual non-employee director grant provision approved by the Company's Board of Directors on April 13, 2021. The RSUs are scheduled to vest and settle at the earlier of the date of the next Annual Meeting of Stockholders or the one-year anniversary of the Grant Date.
F3 Includes 236,202 unvested RSUs.